This application is a National Stage Entry entitled to and hereby claiming priority under 35 U.S.C. §§ 365 and 371 to corresponding PCT Application No. PCT/GB2017/050235, filed Jan. 31, 2017 entitled “Membrane Pump Usage Condition Detection”, which in turn claims priority to G.B. Patent Application No.: 1602391.3, filed Feb. 10, 2016, entitled the same. The disclosures of the above applications are incorporated herein by reference in their entireties.
The present invention relates to a membrane pump usage condition detection system and a method of determining a membrane pump usage condition.
Fluid pumps, for example blood pumps for the extracorporeal circulation of blood are used in a number of medical applications, for example in hemodialysis, and haemodiafiltration.
In hemodialysis machines, it is known to use a disposable cartridge comprising a rigid frame defining fluid pathways and chambers and a flexible membrane covering a surface of the cartridge. The cartridge is loaded into a hemodialysis machine, where pressure, typically pneumatic pressure, exerted on the outside surface of the flexible membrane, causes the membrane to move back and forth. This back and forth action in the region of a chamber acts as a fluid pump, which is thus often referred to as a membrane pump. Such a machine is disclosed in WO 2013/121163, the contents thereof are hereby incorporated by reference.
The movement may also be used to mix two or more fluids in a chamber, such as bicarbonate and acid to create dialysate.
The movement of the flexible membrane may also be used to open and close valves defined in the rigid frame of the disposable cartridge. Such a system is disclosed in WO 2013/110919, the contents thereof are hereby incorporated by reference.
Because of its use in hemodialysis, in pumping and mixing fluids, the cartridge may be referred to as a haemodialysis pulsatile pumping cartridge. Such a disposable cartridge is typically made of a rigid frame of polyethylene and a flexible membrane of polyvinyl chloride (PVC).
In use, the disposable cartridge is loaded in a hemodialysis machine and undergoes repeated deformations in the localised regions of the pump chambers, mixing chambers and valves. In a typical cycle, the machine will perform a priming stage, a treatment stage, including flow balance and ultrafiltration stages following by a purge stage.
Such a dialysis machine relies on volumetric control. Dosing and mixing of fluids is controlled by the volume of the pump chambers which in turn is affected by the flexibility of the membrane. The specific flexibility of the membrane is therefore essential to the accurate running of the dialysis machine. Similarly, flow of fluids into and out of the pump chambers is controlled by inlet and outlet valves which rely on the deformation of the flexible membrane.
Repeated deformations gradually cause plastic deformation of the flexible membrane. Thus the disposable cartridges may be engineered to withstand a specific cycle loading, along with a reserve factor. Once used, the disposable cartridge is disposed of and should not be used again.
Re-use of a cartridge designed for a single cycle, or re-use of a cartridge designed for a specific number of cycles, beyond that number of cycles, may reduce the efficacy of treatment and has the potential to cause damage to the dialysis machine.
Given the typical make-up of the disposable cartridge, and that a typical cycle ends with a purge stage that washes and empties the cartridge to remove any residual fluids, a used cartridge does not visibly show any distinct features, as compared to an unused cartridge. Therefore there is a risk of cartridge re-use, either deliberate or accidental.
Valve leak systems are installed in the dialysis machine to detect if any of the valves on the dialysis cartridge are not closing properly, such that there is a leak of fluid through the valve. The valve leak system comprises first and second conductivity electrodes arranged upstream and downstream of the valve respectively. A conductivity measurement is taken across the electrodes when the valve is closed. For a normally functioning valve, a low conductivity, or indeed no conductivity should be detected when the valve is closed. If a valve is leaking however, a high conductivity is detected, as the leaking fluid carries the charge through the valve, between the first and second conductivity electrodes.
The present invention aims to provide a membrane pump usage condition detection system and a method of determining a membrane pump usage condition and that mitigates one or more of the above problems.
According to a first aspect of the present invention, there is provided a membrane pump usage condition detection system comprising a membrane pump defining a flow path arranged to be opened and closed by at least one valve, a measuring device, a comparator and a signal generator, wherein the measuring device is configured to determine an electrical characteristic between two points on the flow path of the membrane pump, one point arranged upstream of the at least one valve and the other point arranged downstream of the at least one valve, whereby the measuring device measures the electrical characteristic when the at least one valve is closed, and wherein the comparator is configured to monitor the electrical characteristic; and the signal generator is arranged to provide an output signal when the electrical characteristic is indicative of a membrane pump usage condition.
Thus the system provides an output signal characterising the membrane pump usage condition using data from a valve leak system. This may give an operator of a cartridge incorporating the membrane pump, information concerning the overall condition of the cartridge. As data from the valve leak system is used, the membrane pump usage condition detection system requires no additional hardware.
The electrical characteristic may be one of conductance, impedance or capacitance or any other electrical characteristic measurable across the valve.
The detection system may further comprise a processor arranged to receive the output signal. The output signal may be stored in the processor. Thus further analysis may be performed on the identified characteristic. Patterns of deliberate or accidental cartridge re-use may then be monitored.
The membrane pump may be provided on a cartridge. The membrane pump usage condition may be indicative of a cartridge usage condition.
The processor may calculate the specific number of cartridge uses from the electrical characteristic indicative of the membrane pump usage condition.
The output signal may be an error message preventing further cartridge use. This prevents deliberate or accidental cartridge re-use, or re-use of a cartridge beyond a specified number of uses. This may be notified to the user/operator of the dialysis machine in the form of an audible or visual alarm.
The comparator may compare the electrical characteristic with a pre-determined threshold value. Alternatively, the comparator may compare the electrical characteristic with a dynamic threshold value.
The output signal may be provided when the electrical characteristic is above the threshold value. Alternatively, the output signal is provided when the electrical characteristic falls below the threshold value.
The output signal may be an alarm indicating a net fluid removal error. A valve leak could cause net fluid removal error by not fully filing up or emptying the pump with dialysate. Hence, when a valve leak is detected by measuring the frequency an alarm is generated to stop treatment.
The processor may be programmed to permit a set number of cartridge re-uses.
The measuring device may be a pair of electrodes. Alternatively the measuring device may be a pair of capacitance probes.
According to a second aspect of the present invention, there is provided a method of determining a membrane pump usage condition comprising the steps of: providing a dialysis machine including a cartridge having a deformable membrane, the cartridge and deformable membrane together defining a membrane pump, the membrane pump defining a flow path arranged to be opened and closed by at least one valve, a measuring device, a comparator; and a signal generator, configuring the measuring device for determining an electrical characteristic between two points on the flow path of the membrane pump, one point arranged upstream of the at least one valve and the other point arranged downstream of the at least one valve, operating the dialysis machine through a cycle, measuring the electrical characteristic whenever the at least one valve is closed, monitoring the electrical characteristic throughout the cycle using the comparator, providing an output signal when the electrical characteristic is indicative of a membrane pump usage condition.
Thus the method of the present invention provides a measure of cartridge deterioration (and re-use) using the data output of the existing valve leak detection system.
The electrical characteristic may be one of conductance, impedance or capacitance. The cycle may include at least one of a priming stage, a treatment stage, and a purge stage.
The membrane pump usage condition may be indicative of a cartridge usage condition.
The step of determining the membrane pump usage condition includes recording a characteristic value above a limit value. Alternatively, the step of determining the membrane pump usage condition may include recording a series of characteristic values above a limit value.
The characteristic value may be a decay rate of the valve leak frequency following a spike in the valve leak frequency. The characteristic values are observed in the data of the valve leak detection system. The so-called background levels change with cartridge re-use. The background level of the valve leak detection system is observed to spike to higher levels during cartridge re-use. The background level of the valve leak detection system is observed to spike to higher levels and then more rapidly decay during cartridge re-use.
The decay rate of the valve leak frequency following a spike in the valve leak frequency may be indicative of a specific number of cartridge uses. Thus the specific number of cartridge uses may be determined.
The characteristic value may be the mean, median or modal average valve leak frequency during the cycle. This value may be compared to a signature value for a specific cartridge, providing an indication of the level of cartridge re-use.
The cartridge usage condition may be determined using a processor provided on the dialysis machine.
The valve leak frequency may be recorded at a sample rate of 1 sample a second during the cycle. Alternatively, the valve leak frequency may be recorded at an intermittent sample rate during the cycle.
Embodiments of the present invention will now be described, by way of example only, and with references to the accompanying drawings, in which:
A cross section of a dialysis machine 10 is shown schematically in
The cartridge 30 (see
The pneumatic operation of each of the chambers 40, 42, 44, 46 and 48 are substantially similar, such that only the flow balance pump chamber “A” 40 shall be described in detail.
Furthermore, the two inlet valves 50 and the two outlet valves 52 are substantially similar, such that only one inlet valve 50 and one outlet valve 52 shall be described in detail.
Referring back to
In use, the cartridge 30 is retained between the first platen 12 on a first side of the cartridge 30 and the second platen 14 on a second side of the cartridge 30. The second platen 14 has a cartridge engaging surface 15 and a non-cartridge engaging surface 17. Cavities 16 are defined within the cartridge engaging surface 15, which correspond to the concave cavities 34 on the cartridge 30. A fluid port 18 is defined in each of the concave cavities 16, fluidly connecting the cartridge engaging surface 15 and the non-cartridge engaging surface 17, of the second platen 14.
The pneumatic actuators 24 are arranged in fluid communication with the first side of the cartridge 30, through the second platen 14 via the fluid ports 18, and hence the machine facing surface 33 of the flexible membrane 32. The pump chambers and valves are operated pneumatically by actuating the flexible membrane 32 using the pneumatic actuators 24 provided in the machine body 22. In an alternative embodiment the pump chambers and valves are operated hydraulically.
The pump chambers and valves are provided with sensing arrangements 60, each of which include two sensing electrodes, generally termed 70 (see
The sensing arrangements 60 monitor the flow of fluids through the pump chambers and valves along the various fluid pathways. Referring to
The flow balance pump chamber “B” sensing arrangement 60 is arranged with an inlet valve sensing electrode 72 and outlet valve sensing electrode 82. The inlet valve sensing electrode 72 is fixed to the rigid body 31 of the cartridge 30 with the pointed sensing tip 71 exposed to the fluid flowpath 28 at the entrance to the inlet valve 50. The outlet valve sensing electrode 82 is fixed to the rigid body 31 of the cartridge 30 with the pointed sensing tip 71 exposed to the fluid flowpath 28 at the exit of the outlet valve 52.
Thus the inlet valve sensing electrode 72 is provided upstream of the flow balance pump chamber “B” 42, and outlet valve sensing electrode 82 is provided downstream of the flow balance pump chamber “B” 42.
When the cartridge 30 is loaded into the dialysis machine 10, the inlet valve sensing electrode 72 and outlet valve sensing electrode 82 line up with sprung contacts 90, 94 provided in the second platen 14, sandwiching the flexible membrane 32 therebetween.
The sprung contacts 90, 94 are electrically connected to a processor 98, incorporating a sensor circuit, a comparator and a power source, provided in the machine body 22 via electrical connectors 92, 96 respectively.
Thus inlet valve sensing electrode 72 and outlet valve sensing electrode 82 are electrically connected to the processor 98 through the flexible membrane 32. The inlet valve sensing electrode 72 and outlet valve sensing electrode 82, together with the sprung contacts 90, 94, processor 98 and respective connectors 92, 96 form the sensing arrangement 60.
In use at least one of the inlet valve 50 and the outlet valve 52 will always be closed. That is, there are three modes of operation. In an idle mode, both the inlet valve 50 and the outlet valve 52 are closed. Thus there should be no continuous flowpath between the inlet valve sensing electrode 72 and the outlet valve sensing electrode 82.
In a fill mode, the inlet valve 50 is open, and the outlet valve 52 is closed. This allows flow balance pump chamber “B” to be filled. However, there should still be no continuous flowpath between the inlet valve sensing electrode 72 and the outlet valve sensing electrode 82, as the outlet valve is closed. In an empty mode, the inlet valve 50 is closed, and the outlet valve 52 is open. This allows flow balance pump chamber “B” to be emptied. However, there should still be no continuous flowpath between the inlet valve sensing electrode 72 and the outlet valve sensing electrode 82, as the inlet valve 50 is closed. Thus the valve leak system may detect when either of the inlet or outlet valves 50, 52 are leaking using the sensing arrangement 60 shown in
During operation of the dialysis machine 10, the sensing arrangements 60 are used to detect leakage across the pump chambers and valves of the Dialysis Machine.
The sensor circuit of the processor 98, includes an operational amplifier based relaxation oscillator whose frequency is determined by electrical conductance of the fluid path.
In use, an alternating potential difference from the power source is applied across the fluid flowpath 28 by the inlet valve sensing electrode 72. The conductance of the fluid flowpath 28 between the inlet valve 50 and outlet valve 52 of the flow balance pump chamber “B” 42 is measured at the outlet valve sensing electrode 82 by measuring the potential difference detected at the outlet valve sensing electrode 82, as will be described in more detail below. The potential differential provides an indication the conductivity of the fluid flowpath 28. The relaxation oscillator ensures that the sensing arrangement 60 operates with an alternating current with minimal direct current offset. This reduces the galvanic effects on the inlet valve sensing electrode 72 and the outlet valve sensing electrode 82.
The sensor circuit of the processor 98 generates the pulse train from the relaxation oscillator which is sent through the sensing arrangement 60, to output at the processor 98. The output at the processor is a series of pulses. From this series of pulses, a frequency is determined by measuring the time between the pulses, and hence fluid conductivity. This frequency value is known as the valve leak frequency.
The sensing arrangement 60 detects a valve leak in the inlet and outlet valves 50, 52 of the flow balance chamber “B” 42 by performing conductivity checks during operation of the flow balance system. The conductivity along a flow path should not exceed a defined limit if the flow path is interrupted by valves 50, 52. The test is performed once every pump operation. If the inlet or outlet valves 50, 52 fail to close, then the respective pump may draw or expel the fluid associated with that pump the wrong way, which is undesirable. The protective system for this error uses conductivity of the fluid flowpath 28 as a means to determine this failure. Thus in normal operation of the Dialysis Machine, there should never be a conductive path across the whole of the pump, from before the inlet valve 50 to after the outlet valve 52, that has a conductivity of a value equal to or greater than a limit value set by the particular geometry of the cartridge in question. If a conductive path is seen, this may be indicative of one of the valves 50, 52 having failed to close.
Hence the valve leak detection system measures a valve leak frequency value. The valve leak signal is generated by an oscillator and the frequency of the signal is determined by the feedback resistor. The sensing electrodes are connected in parallel to the feedback resistor so that a lower impedance across the valves would cause the total feedback resistor value to decrease, increasing the oscillating frequency.
During normal operation of an exemplary Dialysis Machine having an exemplary cartridge, the relaxation oscillator is tuned to generate a signal of 6 kHz for a resistance of 10 kOhms across the sensing electrodes. The expected detected valve leak frequency value is between 3 kHz and 4 kHz. Should a valve leak frequency value in excess of 6 kHz be detected, a valve leak has occurred.
The valve leak detection system described above may be used to determine membrane pump usage and hence cartridge usage.
A partial valve leak (e.g. due to re-used cartridges) is detected when the variation of detected valve leak frequency value within a pumping cycle increases.
A variation in the detected valve leak frequency value is detected by the comparator within the processor 98 measuring the difference between the minimum and maximum valve leak frequency values measured within one pump cycle.
For the normal operation of an exemplary Dialysis Machine having an exemplary cartridge referred to above, variation of valve leak frequency value is between 200 Hz and 500 Hz. Variations above 1 kHz are considered to be partial valve leak. Thus for this exemplary Dialysis Machine having an exemplary cartridge, the pre-determined threshold value is a valve leak frequency value difference of 1 kHz.
The value used for the partial valve leak is not the absolute frequency but the variation of the frequency within a pumping cycle. When the valve is partially leaking (e.g. due to re-use of cartridges) the frequency signal is not as stable as it normally is: maximum relative difference of the valve leak frequency value within one pump cycle is more than 1 kHz. Normal expected values of absolute frequency are 3 kHz to 4 kHz with a variation of less than 1 kHz within a pumping cycle.
As the valve leak signal is generated by an oscillator and the frequency of the signal is determined by the feedback resistor, a dynamic threshold value for the valve leak frequency value difference may be used instead of the pre-determined threshold value.
The effects on a cartridge 30 during a dialysis treatment cycle can be represented by a typical test cycle. A typical test cycle includes three main stages, flow balance, ultrafiltration and purge. In the first 30 minutes, the dialysis machine 10 is taken through a flow balance stage of the test cycle. The flow balance stage tests the flow balance valves. During the next 30 minutes, the dialysis machine 10 is taken through an ultrafiltration stage of the test cycle. The ultrafiltration stage tests the ultrafiltration valves. The test cycle is then ended with a purge stage. The purge stage empties the cartridge 30 of all dialysate fluids, and cleans the fluid flow paths with reverse osmosis water.
In order to determine the deterioration rates, the same cartridge 30 is forced through repeated test cycles.
With reference to
As can be seen in
With reference to
The valve leak frequency difference limit 250 is shown as a dashed line at 1000 Hz. The valve leak frequency difference limit 250 may be manipulated depending on the deterioration rates displayed by the cartridge 30.
An increase in the valve leak frequency difference values can be seen from the first cycle 200 to the second cycle 210. This increase in the valve leak frequency difference value represents a deterioration in the flexible membrane of the cartridge. A yet greater increase in the valve leak frequency difference values is seen from the second cycle 210 to the third cycle 220. An alarm is raised during the third cycle 220, as the point readings regularly breach the 1000 Hz valve leak frequency difference limit 250.
Thus
With reference to
The valve leak frequency difference limit 350 is shown as a dashed line at 1000 Hz.
Thus the method of determining a cartridge usage condition records the valve leak frequency during the cycle to obtain a characteristic value, and determines the cartridge usage condition based on the characteristic value. The characteristic value may be a single breach of the 1000 Hz valve leak frequency difference limit 250. The characteristic value may be a discreet number of breaches of the 1000 Hz valve leak frequency difference limit 250. The characteristic value may be a decay rate of the valve leak frequency difference following a spike in the valve leak frequency difference. The characteristic value may be the mean, median or modal average valve leak frequency difference during the cycle. The processor 98 may be programmed to monitor any of the preceding characteristic values. On receipt of a characteristic value, the process may send a signal to a graphical user interface, or to an audible or visual alarm to indicate the cartridge usage condition or a signal to prevent activation of the dialysis machine cycle.
Thus the detection system is sensitive enough so that it detects a deterioration of the cartridge membrane before a leak across the valve is established. This allows an operator to prevent use of a cartridge not fit for purpose.
Although the valve leak frequency is described as being measured using the sensing arrangements including sensing electrodes, other sensing arrangements are envisaged. A capacitance probe, which provides a non-contacting fluid flowpath sensing arrangement, is also envisaged, as is an inductance probe which is non-contacting. Other relaxation oscillator types may be used, such as a transistor based relaxation oscillator.
Number | Date | Country | Kind |
---|---|---|---|
1602391 | Feb 2016 | GB | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/GB2017/050235 | 1/31/2017 | WO |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2017/137723 | 8/17/2017 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2696173 | Thormod | Dec 1954 | A |
3338171 | Conklin et al. | Aug 1967 | A |
3468261 | Schmierer | Sep 1969 | A |
3605566 | Vetter | Sep 1971 | A |
3606592 | Madurski et al. | Sep 1971 | A |
3753493 | Mellor | Aug 1973 | A |
3774762 | Lichtenstein | Nov 1973 | A |
3807906 | Breit | Apr 1974 | A |
3921622 | Cole | Nov 1975 | A |
3972320 | Kalman | Aug 1976 | A |
4070725 | Cornelius | Jan 1978 | A |
4142845 | Lepp et al. | Mar 1979 | A |
4161264 | Malmgren | Jul 1979 | A |
4205686 | Harris et al. | Jun 1980 | A |
4353990 | Manske et al. | Oct 1982 | A |
4366061 | Papanek et al. | Dec 1982 | A |
4368261 | Klose et al. | Jan 1983 | A |
4370983 | Lichtenstein | Feb 1983 | A |
4430048 | Fritsch | Feb 1984 | A |
4494912 | Pauliukonis | Jan 1985 | A |
D277991 | Becker | Mar 1985 | S |
4534755 | Calvert et al. | Aug 1985 | A |
4534756 | Nelson | Aug 1985 | A |
4546669 | Fischer et al. | Oct 1985 | A |
4564342 | Weber et al. | Jan 1986 | A |
4599165 | Chevallet | Jul 1986 | A |
4648869 | Bobo, Jr. | Mar 1987 | A |
4666598 | Heath et al. | May 1987 | A |
4710163 | Butterfield | Dec 1987 | A |
4771792 | Seale | Sep 1988 | A |
4828543 | Weiss et al. | May 1989 | A |
4897184 | Shouldice et al. | Jan 1990 | A |
D308249 | Buckley | May 1990 | S |
4969991 | Valadez | Nov 1990 | A |
5000664 | Lawless et al. | Mar 1991 | A |
5012197 | Seiffert et al. | Apr 1991 | A |
5032265 | Jha et al. | Jul 1991 | A |
5055198 | Shettigar | Oct 1991 | A |
5095910 | Powers | Mar 1992 | A |
5103211 | Daoud et al. | Apr 1992 | A |
5126831 | Nakagawara | Jun 1992 | A |
5232434 | Inagaki et al. | Aug 1993 | A |
5252213 | Ahmad et al. | Oct 1993 | A |
D341890 | Sievert et al. | Nov 1993 | S |
D344339 | Yoshikawa et al. | Feb 1994 | S |
5304349 | Polaschegg | Apr 1994 | A |
D347896 | Dickinson et al. | Jun 1994 | S |
D351470 | Scherer et al. | Oct 1994 | S |
5385540 | Abbott et al. | Jan 1995 | A |
5421823 | Kamen et al. | Jun 1995 | A |
5458468 | Ye et al. | Oct 1995 | A |
5476368 | Rabenau et al. | Dec 1995 | A |
5476792 | Ezrielev et al. | Dec 1995 | A |
D370979 | Pascale et al. | Jun 1996 | S |
5558347 | Nicholson | Sep 1996 | A |
5586872 | Skobelev et al. | Dec 1996 | A |
5586873 | Novak et al. | Dec 1996 | A |
5591344 | Kenley et al. | Jan 1997 | A |
5643201 | Peabody et al. | Jul 1997 | A |
5650071 | Brugger et al. | Jul 1997 | A |
5653456 | Mough | Aug 1997 | A |
5658456 | Kenley et al. | Aug 1997 | A |
5665307 | Kirschner et al. | Sep 1997 | A |
5727550 | Montecalvo | Mar 1998 | A |
D395085 | Kenley et al. | Jun 1998 | S |
5788851 | Kenley et al. | Aug 1998 | A |
5807322 | Lindsey et al. | Sep 1998 | A |
5882300 | Malinouskas et al. | Mar 1999 | A |
5948247 | Gillerfalk et al. | Sep 1999 | A |
5957670 | Duncan et al. | Sep 1999 | A |
5995910 | Discenzo | Nov 1999 | A |
6077443 | Goldau | Jun 2000 | A |
6126831 | Goldau et al. | Oct 2000 | A |
6132378 | Marino | Oct 2000 | A |
6143181 | Falkvall et al. | Nov 2000 | A |
6153102 | Kenley et al. | Nov 2000 | A |
6216029 | Paltieli | Apr 2001 | B1 |
6218329 | Singh et al. | Apr 2001 | B1 |
6251279 | Peterson et al. | Jun 2001 | B1 |
6261065 | Nayak et al. | Jul 2001 | B1 |
6303036 | Collins et al. | Oct 2001 | B1 |
6382923 | Gray | May 2002 | B1 |
6514462 | Simons | Feb 2003 | B1 |
6558347 | Jhuboo et al. | May 2003 | B1 |
6582206 | Schluecker | Jun 2003 | B2 |
6626832 | Paltieli et al. | Sep 2003 | B1 |
6626878 | Leisner et al. | Sep 2003 | B1 |
6645176 | Christenson et al. | Nov 2003 | B1 |
6663829 | Kjellstrand | Dec 2003 | B1 |
6733476 | Christenson et al. | May 2004 | B2 |
6743204 | Christenson et al. | Jun 2004 | B2 |
6801646 | Pena et al. | Oct 2004 | B1 |
6814547 | Childers et al. | Nov 2004 | B2 |
6967002 | Edgson et al. | Nov 2005 | B1 |
7040142 | Burbank | May 2006 | B2 |
7107837 | Lauman | Sep 2006 | B2 |
7153286 | Busby et al. | Dec 2006 | B2 |
7220358 | Schacht et al. | May 2007 | B2 |
7284964 | McDowell et al. | Oct 2007 | B2 |
7383721 | Parsons | Jun 2008 | B2 |
7434312 | Christenson et al. | Oct 2008 | B2 |
7494590 | Felding et al. | Feb 2009 | B2 |
7604398 | Akers et al. | Oct 2009 | B1 |
7648627 | Beden et al. | Jan 2010 | B2 |
7857976 | Bissler et al. | Dec 2010 | B2 |
7874999 | Busby | Jan 2011 | B2 |
7896197 | Furey et al. | Mar 2011 | B2 |
D641882 | Hickey et al. | Jul 2011 | S |
8114043 | Muller | Feb 2012 | B2 |
8132388 | Nagy et al. | Mar 2012 | B2 |
8137184 | Ajiro et al. | Mar 2012 | B2 |
8137300 | Han et al. | Mar 2012 | B2 |
8167431 | DeCusatis et al. | May 2012 | B2 |
8187184 | Muller et al. | May 2012 | B2 |
8192388 | Hogard | Jun 2012 | B2 |
8197431 | Bennison | Jun 2012 | B2 |
8221320 | Bouton | Jul 2012 | B2 |
8348850 | Frinak et al. | Jan 2013 | B2 |
8360977 | Marttila et al. | Jan 2013 | B2 |
8529490 | Wariar et al. | Sep 2013 | B2 |
8535522 | Fulkerson et al. | Sep 2013 | B2 |
8535525 | Heyes et al. | Sep 2013 | B2 |
D693469 | Chung et al. | Nov 2013 | S |
8597505 | Fulkerson et al. | Dec 2013 | B2 |
D702842 | Hyde et al. | Apr 2014 | S |
8685244 | Heyes et al. | Apr 2014 | B2 |
8696571 | Marttila et al. | Apr 2014 | B2 |
8708908 | Bouton | Apr 2014 | B2 |
8708946 | Han et al. | Apr 2014 | B2 |
D705432 | Lura et al. | May 2014 | S |
8798908 | Bourdeaut | Aug 2014 | B2 |
8801646 | Han et al. | Aug 2014 | B2 |
D714454 | Amemiya et al. | Sep 2014 | S |
D714946 | Lura et al. | Oct 2014 | S |
8926544 | Hogard et al. | Jan 2015 | B2 |
D724740 | Collins et al. | Mar 2015 | S |
8974394 | Frinak et al. | Mar 2015 | B2 |
9011334 | Bouton | Apr 2015 | B2 |
D735868 | Mareguddi et al. | Aug 2015 | S |
9220825 | Buckberry | Dec 2015 | B2 |
D781410 | Ritter et al. | Mar 2017 | S |
9744285 | Heyes et al. | Aug 2017 | B2 |
9833553 | Higgitt | Dec 2017 | B2 |
10314962 | Buckberry | Jun 2019 | B2 |
10456516 | Heyes et al. | Oct 2019 | B2 |
D867597 | Bauer et al. | Nov 2019 | S |
10543305 | Buckberry et al. | Jan 2020 | B2 |
D879967 | Verguidi et al. | Mar 2020 | S |
D907211 | Spurling | Jan 2021 | S |
10881775 | Wallace | Jan 2021 | B2 |
10960120 | Wallace | Mar 2021 | B2 |
D924410 | Mendoza et al. | Jul 2021 | S |
D938046 | Gupta et al. | Dec 2021 | S |
11365728 | Westenbrink | Jun 2022 | B2 |
11571499 | Milad et al. | Feb 2023 | B2 |
11583618 | Buckberry et al. | Feb 2023 | B2 |
20030217962 | Childers et al. | Nov 2003 | A1 |
20040195157 | Mullins et al. | Oct 2004 | A1 |
20040206703 | Bosetto et al. | Oct 2004 | A1 |
20040215129 | Edgson et al. | Oct 2004 | A1 |
20040223857 | Kline | Nov 2004 | A1 |
20050020961 | Burbank et al. | Jan 2005 | A1 |
20050205476 | Chevallet et al. | Sep 2005 | A1 |
20050209547 | Burbank et al. | Sep 2005 | A1 |
20050234384 | Westberg | Oct 2005 | A1 |
20060121623 | He et al. | Jun 2006 | A1 |
20070083193 | Werneth et al. | Apr 2007 | A1 |
20080006089 | Adnan | Jan 2008 | A1 |
20080200865 | Bedingfield | Aug 2008 | A1 |
20080283096 | Scheringer et al. | Nov 2008 | A1 |
20090007642 | Busby et al. | Jan 2009 | A1 |
20090009290 | Kneip et al. | Jan 2009 | A1 |
20090012450 | Shah et al. | Jan 2009 | A1 |
20090012452 | Slepicka et al. | Jan 2009 | A1 |
20090012457 | Childers et al. | Jan 2009 | A1 |
20090101550 | Muller et al. | Apr 2009 | A1 |
20090211975 | Brugger et al. | Aug 2009 | A1 |
20090230043 | Heyes et al. | Sep 2009 | A1 |
20100043694 | Patel | Feb 2010 | A1 |
20100045471 | Meyers | Feb 2010 | A1 |
20100089807 | Heyes et al. | Apr 2010 | A1 |
20100139254 | Sebestyen et al. | Jun 2010 | A1 |
20100263687 | Braun et al. | Oct 2010 | A1 |
20110009797 | Kelly et al. | Jan 2011 | A1 |
20110034850 | Jonsson | Feb 2011 | A1 |
20110132838 | Curtis et al. | Jun 2011 | A1 |
20110168614 | Pouchoulin et al. | Jul 2011 | A1 |
20120164022 | Muginstein et al. | Jun 2012 | A1 |
20120269907 | Coates | Oct 2012 | A1 |
20120276549 | Cunningham et al. | Nov 2012 | A1 |
20120292237 | Heyes et al. | Nov 2012 | A1 |
20120308431 | Kotsos et al. | Dec 2012 | A1 |
20130037465 | Heyes et al. | Feb 2013 | A1 |
20130056419 | Curtis | Mar 2013 | A1 |
20130153495 | Kelly et al. | Jun 2013 | A1 |
20130199998 | Kelly et al. | Aug 2013 | A1 |
20130274642 | Soykan et al. | Oct 2013 | A1 |
20140224736 | Heide | Aug 2014 | A1 |
20140251885 | Heyes | Sep 2014 | A1 |
20140271106 | Alessandro | Sep 2014 | A1 |
20140299544 | Wilt et al. | Oct 2014 | A1 |
20150027951 | Wallace | Jan 2015 | A1 |
20150076053 | Higgitt | Mar 2015 | A1 |
20150112119 | Buckberry | Apr 2015 | A1 |
20150129481 | Higgitt et al. | May 2015 | A1 |
20150238673 | Gerber et al. | Aug 2015 | A1 |
20150258263 | Hogard | Sep 2015 | A1 |
20150352269 | Gerber et al. | Dec 2015 | A1 |
20150359954 | Gerber et al. | Dec 2015 | A1 |
20160045656 | Buckberry | Feb 2016 | A1 |
20160051743 | Buckberry | Feb 2016 | A1 |
20160058933 | Ballantyne et al. | Mar 2016 | A1 |
20160076535 | Clifton | Mar 2016 | A1 |
20160077644 | Ritter et al. | Mar 2016 | A1 |
20160199558 | Buckberry | Jul 2016 | A1 |
20170056576 | Doyle et al. | Mar 2017 | A1 |
20170167983 | Klomp et al. | Jun 2017 | A1 |
20170252498 | Heyes et al. | Sep 2017 | A1 |
20170296730 | Soto et al. | Oct 2017 | A1 |
20180133391 | Heyes et al. | May 2018 | A1 |
20180154059 | Heyes et al. | Jun 2018 | A1 |
20180193545 | Crnkovich et al. | Jul 2018 | A1 |
20180344915 | Wallace | Dec 2018 | A1 |
20190001042 | Buckberry | Jan 2019 | A1 |
20190015577 | Garrido et al. | Jan 2019 | A1 |
20190024654 | May | Jan 2019 | A1 |
20190358381 | Westenbrink | Nov 2019 | A1 |
20190374698 | Buckberry et al. | Dec 2019 | A1 |
20190376504 | Westenbrink | Dec 2019 | A1 |
20190385434 | Yuds et al. | Dec 2019 | A1 |
20200030515 | Merchant | Jan 2020 | A1 |
20200075159 | Bardorz et al. | Mar 2020 | A1 |
20200268958 | Heyes et al. | Aug 2020 | A1 |
20200276372 | Milad et al. | Sep 2020 | A1 |
20200330671 | Buckberry et al. | Oct 2020 | A1 |
20210110920 | Heyes et al. | Apr 2021 | A1 |
20220001087 | Heyes et al. | Jan 2022 | A1 |
20220160943 | Buckberry et al. | May 2022 | A9 |
20220241480 | Fincham | Aug 2022 | A1 |
20220241573 | Fincham | Aug 2022 | A1 |
Number | Date | Country |
---|---|---|
81430 | Aug 1997 | CA |
10024447 | Nov 2001 | DE |
004375764-0001 | Oct 2017 | EA |
004375764-0002 | Oct 2017 | EA |
007955125-0002 | Jun 2020 | EA |
0165751 | Dec 1985 | EP |
0754468 | Jan 1997 | EP |
2219703 | Aug 2010 | EP |
2955512 | Dec 2015 | EP |
2 310 136 | Dec 1976 | FR |
9007955125-0001 | May 2020 | GB |
9007955125-0002 | May 2020 | GB |
H04266740 | Feb 1991 | JP |
H06261872 | Sep 1994 | JP |
H06261872 | Sep 1994 | JP |
H07174659 | Jul 1995 | JP |
2000130334 | May 2000 | JP |
D1645323 | Nov 2020 | JP |
WO 8101800 | Jul 1981 | WO |
WO 9100113 | Jan 1991 | WO |
WO 9116542 | Oct 1991 | WO |
1995006205 | Mar 1995 | WO |
WO 9525893 | Sep 1995 | WO |
WO 9625214 | Aug 1996 | WO |
WO 9710013 | Mar 1997 | WO |
WO 9728368 | Aug 1997 | WO |
WO 9929356 | Jun 1999 | WO |
WO 2000006217 | Feb 2000 | WO |
WO 0057935 | Oct 2000 | WO |
WO 02066833 | Aug 2002 | WO |
WO 02081917 | Oct 2002 | WO |
WO 2003101510 | Dec 2003 | WO |
WO 2005044339 | May 2005 | WO |
WO 2005080794 | Sep 2005 | WO |
WO 2006120415 | Nov 2006 | WO |
WO 2006120417 | Nov 2006 | WO |
WO 2008100671 | Aug 2008 | WO |
WO 2008106191 | Sep 2008 | WO |
WO 2008135245 | Nov 2008 | WO |
WO 2009006489 | Jan 2009 | WO |
WO 2009024333 | Feb 2009 | WO |
WO 2009038834 | Mar 2009 | WO |
WO 2009061608 | May 2009 | WO |
WO 2009127624 | Oct 2009 | WO |
WO 2010089130 | Aug 2010 | WO |
WO 2010146343 | Dec 2010 | WO |
WO 2011027118 | Mar 2011 | WO |
WO 2011068885 | Jun 2011 | WO |
WO 2011105697 | Sep 2011 | WO |
WO 2011105698 | Sep 2011 | WO |
WO 2013052680 | Apr 2013 | WO |
WO 2013057109 | Apr 2013 | WO |
WO 2013110906 | Aug 2013 | WO |
WO 2013110919 | Aug 2013 | WO |
WO 2013114063 | Aug 2013 | WO |
WO 2013121162 | Aug 2013 | WO |
WO-2013110906 | Aug 2013 | WO |
WO-2013110919 | Aug 2013 | WO |
WO-2013121163 | Aug 2013 | WO |
WO 2014072195 | May 2014 | WO |
WO 2014082855 | Jun 2014 | WO |
WO 2014155121 | Oct 2014 | WO |
WO 2015007596 | Jan 2015 | WO |
WO 2015022537 | Feb 2015 | WO |
WO 2016016870 | Feb 2016 | WO |
WO-2017137723 | Aug 2017 | WO |
WO-2018115816 | Jun 2018 | WO |
Entry |
---|
International Search Report and Written Opinon issued for International Application No. PCT/GB2017/050235, dated Apr. 10, 2017. |
Search Report issued for GB1602391.3, dated Sep. 16, 2016. |
Ergo-Express Motorized Dialysis Cart, Aug. 14, 2017, youtube.com [online], [site visited Jan. 9, 2022], Available from internet, URL: <https://www.youtube.com/watch?v=j4rAXthOmbY> (Year: 2017). |
He et al., “A Fluorescent Sensor with High Selectivity and Sensitivity for Potassium in Water,” Journal of the American Chemical Society 2003 125 (6), 1468-1469. |
Home Dialysis Tescon Aqua Tech, Aug. 1, 2020, youtube.com [online], [site visited Jan. 9, 2022], Available from internet, URL: <https:// www.youtube.com/watch?v=WLLPZoS_mz4> (Year: 2020). |
Kivi, Air Embolism, Healthline, Aug. 20, 2012, p. 1-5. |
LHO2028 Portable Hemodialysis Machine, date unknown, aliexpress.com [online], [site visited Jan. 4, 2022], Available from internet: <https ://www.aliexpress.com/item/1005003324875329.html?randl_currency=USD&_randl_shipto=US&src=google&afffcid=1003bab3b8db4e93b9ba88522a14cfc1-1641319351626-05232-UneMJZVf&aff_fsk=UneMJZVf&aff_platform=aaf&sk=UneMJZVf&aff_trace_key= (Year: 2022). |
Medical Hemodialysis Machine, date unknown, aliexpress.com [online], [site visited Jan. 4, 2022], Available from internet: <https://www.aliexpress.com/item/1005003445721549.html?_ randl_currency=USD&_randl_shipto=US&src=google&aff_fcid=a524f3f9cd9b4976b6b47962f3439d62-1641319166409-02691-UneMJZVf&aff_fsk=UneMJZVf&aff_platform=aaf&sk=UneMJZVf&aff_trace_key=a524f3f9cd9b4976b6b47962f3439d62-1641319166409-02691-UneMJZVf&terminal_id=d0c2cca4b7664d128cb4801 a9ef03ff2> (Year: 2022). |
Millenium HX Portable Dialysis Water System, Jul. 2, 2014, youtube.com [online], [site visited Jan. 10, 2022], Available from internet, URL: <https://www.youtube.com/watch?v=IGEbPi2CDsw> (Year: 2014). |
Portable home dialysis device, Nov. 2, 2017, med-technews.com [online], [site visited Jan. 4, 2022], Available from internet: <https://www.med-technews.com/news/portable-home-dialysis-device-to-launch-next-year/ (Year: 2017). |
European Patent Office, “International Preliminary Report on Patentability,” issued in International Patent Application No. PCT/GB2017/053738, dated Jun. 25, 2019 (8 pages). |
European Patent Office, “International Preliminary Report and Written Opinion,” issued in International Patent Application No. PCT/GB2017/053738, dated Feb. 27, 2018 (11 pages). |
Number | Date | Country | |
---|---|---|---|
20190024654 A1 | Jan 2019 | US |